Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Plos One
|
June 24, 2025
Prioritizing challenges in AI adoption for the legal domain: A systematic review and expert-driven AHP analysis
Sihyun Kim, Sangyoon Yi, Sung-Pil Park
Biometrics
|
June 22, 2023
Hierarchical nuclear norm penalization for multi-view data integration
Sangyoon Yi, Raymond Ka Wai Wong, Irina Gaynanova
Genome Biology
|
July 14, 2021
2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies
Sangyoon Yi, Xianyang Zhang, Lu Yang, et al.
Computers in Biology and Medicine
|
January 3, 2026
1-oxa-3,7-diazaspiro[4.5]decan-2-one derivatives as potent KRAS-G12D inhibitors: A multidisciplinary approach integrating machine learning, synthesis, and biological evaluation
Sungwook Ryu, Mohammad Hassan Baig, Umesh Panwar, et al.
Archiv Der Pharmazie
|
February 4, 2026
HBE-843, a Novel, Potent, and Selective EGFR Targeting PROTAC for the Treatment of Non-Small-Cell Lung Cancer
Mohammad Hassan Baig, Chang Joong Kim, Nale Sagar Dattatraya, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Plos One
|
June 24, 2025
Prioritizing challenges in AI adoption for the legal domain: A systematic review and expert-driven AHP analysis
Sihyun Kim, Sangyoon Yi, Sung-Pil Park
Biometrics
|
June 22, 2023
Hierarchical nuclear norm penalization for multi-view data integration
Sangyoon Yi, Raymond Ka Wai Wong, Irina Gaynanova
Genome Biology
|
July 14, 2021
2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies
Sangyoon Yi, Xianyang Zhang, Lu Yang, et al.
Computers in Biology and Medicine
|
January 3, 2026
1-oxa-3,7-diazaspiro[4.5]decan-2-one derivatives as potent KRAS-G12D inhibitors: A multidisciplinary approach integrating machine learning, synthesis, and biological evaluation
Sungwook Ryu, Mohammad Hassan Baig, Umesh Panwar, et al.
Archiv Der Pharmazie
|
February 4, 2026
HBE-843, a Novel, Potent, and Selective EGFR Targeting PROTAC for the Treatment of Non-Small-Cell Lung Cancer
Mohammad Hassan Baig, Chang Joong Kim, Nale Sagar Dattatraya, et al.
Page
of 1